Orphans and Incentives Developing Technology to Address Emerging Infections (1997) / Chapter Skim
Currently Skimming:
Appendix B
Appendix B
Pages 60-62
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 60... ...
3. In which of the areas indicated in the public health agenda and priorities list is industry already working, who is doing so, and what are they doing?
|
From page 61... ...
ELEMENT 3: OTHER MODELS AND MECHANISMS Special Disease-Focused Initiatives: Malaria Vaccine Development Board Phillip Russell (Johns Hopkins School of Hygiene and Public Health) International AIDS Vaccine Initiative (IAVI)
|
From page 62... ...
Antimicrobial Resistance and Labeling Combination Products: Vaccines and Pharmaceuticals Special Mechanisms to Expedite Approval (e.g., fast-track mechanisms) Use of Foreign Data/ICH Activities Product Availability From the Food and Drug Administration: Elaine Esber Mark Goldberger Jeffrey Murray Stuart Nightingale From the Forum on Emerging Infections: Member Representatives from Industry 10:30 ADJOURN
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.